Health
Coronavirus vaccine from Oxford and AstraZeneca trial could go to regulators by end of 2020 – ABC News
The chief investigator of the global clinical trials for the Oxford coronavirus vaccine candidate says it could go before regulators this year — once scientists are satisfied it works.
Trial data for the University of Oxford and AstraZeneca’s possible coronavirus vaccine could be given to regulators this year but corners cannot be cut to speed up approval for emergency use, a scientist leading the trials says.
Key points:
- The lead scientist in the Oxford Vaccine Group trial says the trial data would go to regulators once the scientists were satisfied with it
- Andrew Pollard says they would need evidence it works before allowing countries to fast-track producti…
-
Business15 hours ago1 ASX dividend stock down 43% I’d buy right now
-
Noosa News15 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Noosa News14 hours agoQueen Street Mall to get a 3D digital billboard; Dutton dumps controversial plans to end flexible work; Measles alert for tourist hotspots
-
Business19 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?